Literature DB >> 12879416

Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.

Takahisa Sasaki1.   

Abstract

The differentiation and functions of osteoclasts (OC) are regulated by osteoblast-derived factors such as receptor activator of NFKB ligand (RANKL) that stimulates OC formation, and a novel secreted member of the TNF receptor superfamily, osteoprotegerin (OPG), that negatively regulates osteoclastogenesis. In examination of the preosteoclast (pOC) culture, pOCs formed without any additives expressed tartrate-resistant acid phosphatase (TRAP), but showed little resorptive activity. pOC treated with RANKL became TRAP-positive OC, which expressed intense vacuolar-type H(+)-ATPase and exhibited prominent resorptive activity. Such effects of RANKL on pOC were completely inhibited by addition of OPG. OPG inhibited ruffled border formation in mature OC and reduced their resorptive activity, and also induced apoptosis of some OC. Although OPG administration significantly reduced trabecular bone loss in the femurs of ovariectomized (OVX) mice, the number of TRAP-positive OC in OPG-administered OVX mice was not significantly decreased. Rather, OPG administration caused the disappearance of ruffled borders and decreased H(+)-ATPase expression in most OC. OPG deficiency causes severe osteoporosis. We also examined RANKL localization and OC induction in periodontal ligament (PDL) during experimental movement of incisors in OPG-deficient mice. Compared to wild-type OPG (+/+) littermates, after force application, TRAP-positive OC were markedly increased in the PDL and alveolar bone was severely destroyed in OPG-deficient mice. In both wild-type and OPG-deficient mice, RANKL expression in osteoblasts and fibroblasts became stronger by force application. These in vitro and in vivo studies suggest that RANKL and OPG are important regulators of not only the terminal differentiation of OC but also their resorptive function. To determine resorptive functions of OC, we further examined the effects of specific inhibitors of H(+)-ATPase, bafilomycin A1, and lysosomal cysteine proteinases (cathepsins), E-64, on the ultrastructure, expression of these enzymes and resorptive functions of cultured OC. In bafilomycin A1-treated cultures, OC lacked ruffled borders, and H(+)-ATPase expression and resorptive activity were significantly diminished. E-64 treatment did not affect the ultrastructure and the expression of enzyme molecules in OC, but significantly reduced resorption lacuna formation, by inhibition of cathepsin activity. Lastly, we examined the expression of H(+)-ATPase, cathepsin K, and matrix metalloproteinase-9 in odontoclasts (OdC) during physiological root resorption in human deciduous teeth, and found that there were no differences in the expression of these molecules between OC and OdC. RANKL was also detected in stromal cells located on resorbing dentine surfaces. This suggests that there is a common mechanism in cellular resorption of mineralized tissues such as bone and teeth. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879416     DOI: 10.1002/jemt.10370

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  30 in total

1.  Clinical Characteristics of Localized Aggressive Periodontitis in Primary Dentition.

Authors:  Karina Miller; Tina Treloar; Marcio Guelmann; Wellington J Rody; Luciana M Shaddox
Journal:  J Clin Pediatr Dent       Date:  2017-10-31       Impact factor: 1.065

2.  In vivo effects of different orthodontic loading on root resorption and correlation with mechanobiological stimulus in periodontal ligament.

Authors:  Jingxiao Zhong; Junning Chen; Richard Weinkamer; M Ali Darendeliler; Michael V Swain; Andrian Sue; Keke Zheng; Qing Li
Journal:  J R Soc Interface       Date:  2019-05-31       Impact factor: 4.118

3.  Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.

Authors:  Kim Henriksen; Jeppe Gram; Pernille Høegh-Andersen; Rune Jemtland; Thor Ueland; Morten H Dziegiel; Sophie Schaller; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

4.  Bovine dentine organic matrix down-regulates osteoclast activity.

Authors:  Wantida Sriarj; Kazuhiro Aoki; Keiichi Ohya; Yuzo Takagi; Hitoyata Shimokawa
Journal:  J Bone Miner Metab       Date:  2009-03-20       Impact factor: 2.626

Review 5.  Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?

Authors:  W Jeffcoate
Journal:  Diabetologia       Date:  2004-08-21       Impact factor: 10.122

Review 6.  Pathways in external apical root resorption associated with orthodontia.

Authors:  J K Hartsfield
Journal:  Orthod Craniofac Res       Date:  2009-08       Impact factor: 1.826

7.  TGF-β in dentin matrix extract induces osteoclastogenesis in vitro.

Authors:  Wannakorn Sriarj; Kazuhiro Aoki; Keiichi Ohya; Mariko Takahashi; Yuzo Takagi; Hitoyata Shimokawa
Journal:  Odontology       Date:  2013-12-24       Impact factor: 2.634

8.  Ultrasound enhances the healing of orthodontically induced root resorption in rats.

Authors:  Zhifeng Liu; Juan Xu; Lingling E; Dongsheng Wang
Journal:  Angle Orthod       Date:  2011-07-25       Impact factor: 2.079

9.  Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats.

Authors:  Jianping Zhou; Gang Feng; Wenwen Zhou; Aishu Ren; Yang Wu; Dingming Zhang; Hongwei Dai
Journal:  J Orofac Orthop       Date:  2011-11-30       Impact factor: 1.938

10.  Management of internal inflammatory root resorption using injectable platelet-rich fibrin revascularization technique: a clinical study with cone-beam computed tomography evaluation.

Authors:  Mohamed Nageh; Lamiaa A Ibrahim; Fatma M AbuNaeem; Engy Salam
Journal:  Clin Oral Investig       Date:  2021-08-13       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.